CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Novamind Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Novamind Inc
10 WANLESS AVENUE, SUITE 201
Phone: (647) 953-9512p:647 953-9512 TORONTO, ON  M4N 1V6  Canada Fax: (416) 481-2222f:416 481-2222
This company was Merged or Acquired on 6/10/2022.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Novamind Inc. is a Canada-based mental health company. The Company enables safe access to psychedelic medicine through a network of psychiatry clinics, and clinical research sites. It provides mental health services through its subsidiary, Cedar Psychiatry Inc. (Cedar Psychiatry) and provides clinical trial services through its other subsidiary, Cedar Clinical Research Inc. (CCR). Cedar Psychiatry offers psychotherapy, psychiatric medication management, transcranial magnetic stimulation (TMS) and ketamine-assisted psychotherapy. CCR specializes in hosting Phase I to Phase IV clinical trials and its research is focused on emerging treatment options in neuropsychiatry on behalf of third-party sponsors. CCR operates a research center in Springville, Utah, which provides select contract research organization (CRO) services for pharmaceutical companies. CCR is also developing psychedelic-assisted psychotherapy treatment protocols to provide patients with evidence-based therapies.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20226/30/2021Yes----

Industries
SIC Code Description
8093 Specialty outpatient facilities, not elsewhere classified
8049 Offices and clinics of health practitioners, not elsewhere classified
8011 Offices and clinics of doctors of medicine
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director YaronConforti 12/22/2020 12/22/2020
Chief Financial Officer, Company Secretary JingPeng 12/22/2020 12/22/2020
Chief Operating Officer PrakashGowd 2/1/2022 2/1/2022
4 additional Officers and Directors records available in full report.

Business Names
Business Name
Hinterland Metals inc
HMI
HN2
NM
Stakeholder Gold Corp.

General Information
Outstanding Shares: 54,927,163 (As of 4/14/2022)
Stock Exchange: CNQ
Fax Number: (416) 481-2222


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 2, 2024